ERT Prevents Lung Health Decline With Classic Fabry, Study Suggests

ERT Prevents Lung Health Decline With Classic Fabry, Study Suggests

324378

ERT Prevents Lung Health Decline With Classic Fabry, Study Suggests

People with classic Fabry disease due to a common disease-causing mutation who don’t smoke can still have poorer lung health and symptoms like dry cough and shortness of breath, but these symptoms can stabilize with enzyme replacement therapy (ERT), a small study in Finland suggests. These findings, in a group of adult classic Fabry patients followed for about five years, suggest that ERT works to preserve pulmonary function in addition to its well-established benefits for kidney and…

You must be logged in to read/download the full post.